JNJ - JOHNSON & JOHNSON
154.14
-0.080 -0.052%
Share volume: 8,980,403
Last Updated: 05-12-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$154.22
-0.08
0.00%
View ratios
| Fiscal Date | 07-02-2023 | 10-01-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-29-2024 | 12-29-2024 | 03-30-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 07-31-2023 | 10-27-2023 | 02-13-2025 | 05-01-2024 | 07-25-2024 | 10-23-2024 | 02-13-2025 | 04-23-2025 | |
| Total revenue | 25.530 B | 21.351 B | 21.395 B | 21.383 B | 22.447 B | 22.471 B | 22.520 B | 21.893 B | |
| Cost of revenue | 8.212 B | 6.606 B | 6.798 B | 6.511 B | 6.869 B | 6.963 B | 7.128 B | 7.357 B | |
| Gross profit | 17.318 B | 14.745 B | 14.597 B | 14.872 B | 15.578 B | 15.508 B | 15.392 B | 14.536 B | |
| -14.86% | -1.00% | 1.88% | 4.75% | -0.45% | -0.75% | -5.56% | |||
| Operating expenses | 10.494 B | 8.847 B | 10.348 B | 8.799 B | 9.315 B | 10.430 B | 11.768 B | 8.337 B | |
| Selling general and admin | 6.665 B | 5.400 B | 5.810 B | 5.257 B | 5.681 B | 5.478 B | 6.453 B | 5.112 B | |
| Research and development | 3.829 B | 3.447 B | 4.538 B | 3.542 B | 3.634 B | 4.952 B | 5.315 B | 3.225 B | |
| Total expenses | 18.706 B | 15.453 B | 10.404 B | 8.963 B | 9.302 B | 10.471 B | 11.810 B | 8.354 B | |
| -17.39% | -32.67% | -13.85% | 3.78% | 12.57% | 12.79% | -29.26% | |||
| Operating income | 6.824 B | 5.898 B | 4.193 B | 5.909 B | 6.276 B | 5.037 B | 3.582 B | 6.182 B | |
| Ebit | 6.824 B | 5.898 B | 4.614 B | 3.505 B | 5.623 B | 3.239 B | 3.743 B | 13.503 B | |
| Pretax income | 6.762 B | 5.217 B | 4.826 B | 3.714 B | 5.748 B | 3.338 B | 3.887 B | 13.631 B | |
| -22.85% | -7.49% | -23.04% | 54.77% | -41.93% | 16.45% | 250.68% | |||
| Income tax | 1.618 B | 908.000 M | 694.000 M | 459.000 M | 1.062 B | 644.000 M | 456.000 M | 2.632 B | |
| Net income basic | 5.144 B | 26.028 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 405.99% | -100.00% | ||||||||
| Net income | 5.144 B | 26.028 B | 4.049 B | 3.255 B | 4.686 B | 2.694 B | 3.431 B | 10.999 B | |
| 405.99% | -84.44% | -19.61% | 43.96% | -42.51% | 27.36% | 220.58% |
